Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 49741.37 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 31-12-2020, the company reported a Consolidated Total Income of Rs 4038.53 Crore, up 4.63 % from last quarter Total Income of Rs 3859.96 Crore and up 4.55 % from last year same quarter Total Income of Rs 3862.86 Crore. Company reported net profit after tax of Rs 441.18 Crore in latest quarter.
Investment Rationale
The stock has broken out of a trendline resistance on good volumes, triggering resumption of the uptrend. Further, a sustained trade beyond Rs 1,100 will trigger a breakout from a huge rounding bottom formation and Nov 2017 highs. RSI is also suggesting an up move.
Promoter/FII Holdings
Promoters held 46.9 per cent stake in the company as of June 30, 2020, while FIIs held 20.4 per cent, DIIs 20.1 per cent and public and others 12.6 per cent.
